| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diarrhea | 12 | 2016 | 311 | 2.550 |
Why?
|
| Inflammatory Bowel Diseases | 10 | 2015 | 328 | 2.270 |
Why?
|
| Colon | 22 | 2010 | 361 | 1.520 |
Why?
|
| Gastrointestinal Diseases | 6 | 2016 | 341 | 1.130 |
Why?
|
| Gastrointestinal Hemorrhage | 6 | 2018 | 225 | 0.890 |
Why?
|
| Intestine, Small | 4 | 2014 | 287 | 0.870 |
Why?
|
| Crohn Disease | 6 | 2014 | 291 | 0.740 |
Why?
|
| Sodium | 11 | 2001 | 281 | 0.660 |
Why?
|
| Breath Tests | 4 | 2015 | 182 | 0.640 |
Why?
|
| Disability Evaluation | 2 | 2012 | 197 | 0.640 |
Why?
|
| beta Catenin | 6 | 2008 | 209 | 0.630 |
Why?
|
| Intestinal Absorption | 12 | 2016 | 170 | 0.630 |
Why?
|
| Intestinal Mucosa | 14 | 2016 | 765 | 0.590 |
Why?
|
| Diabetes Complications | 3 | 2009 | 199 | 0.580 |
Why?
|
| Capsule Endoscopy | 1 | 2018 | 20 | 0.560 |
Why?
|
| Serologic Tests | 3 | 2014 | 125 | 0.510 |
Why?
|
| Feces | 4 | 2016 | 725 | 0.440 |
Why?
|
| Alopecia | 1 | 2015 | 41 | 0.440 |
Why?
|
| Leukocyte L1 Antigen Complex | 2 | 2016 | 19 | 0.440 |
Why?
|
| Mexican Americans | 2 | 2006 | 166 | 0.440 |
Why?
|
| Bile Acids and Salts | 4 | 2014 | 257 | 0.410 |
Why?
|
| Hyperplasia | 7 | 2008 | 189 | 0.400 |
Why?
|
| Diet Therapy | 1 | 2013 | 41 | 0.400 |
Why?
|
| Antibodies, Fungal | 3 | 2012 | 13 | 0.390 |
Why?
|
| Intestinal Diseases | 1 | 2013 | 68 | 0.390 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 3 | 2012 | 40 | 0.380 |
Why?
|
| Amyloidosis | 1 | 2013 | 71 | 0.380 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2015 | 233 | 0.370 |
Why?
|
| Disease Management | 1 | 2016 | 564 | 0.370 |
Why?
|
| Colitis, Ulcerative | 3 | 2014 | 216 | 0.370 |
Why?
|
| Chronic Disease | 7 | 2016 | 1235 | 0.370 |
Why?
|
| Cell Division | 6 | 2005 | 731 | 0.320 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2008 | 60 | 0.320 |
Why?
|
| Colonic Neoplasms | 2 | 2004 | 265 | 0.320 |
Why?
|
| Precancerous Conditions | 2 | 2004 | 283 | 0.320 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2012 | 405 | 0.320 |
Why?
|
| Antidiarrheals | 1 | 2009 | 18 | 0.310 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2014 | 267 | 0.310 |
Why?
|
| Glutens | 1 | 2009 | 11 | 0.300 |
Why?
|
| Malabsorption Syndromes | 2 | 2009 | 29 | 0.300 |
Why?
|
| Humans | 49 | 2018 | 131759 | 0.290 |
Why?
|
| Ileum | 6 | 1990 | 124 | 0.290 |
Why?
|
| Calcium, Dietary | 2 | 2010 | 37 | 0.290 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2008 | 19 | 0.280 |
Why?
|
| Cytoskeletal Proteins | 4 | 2005 | 279 | 0.280 |
Why?
|
| Stomach Ulcer | 1 | 2008 | 94 | 0.270 |
Why?
|
| Diet | 3 | 2013 | 1119 | 0.270 |
Why?
|
| Cecum | 4 | 1992 | 26 | 0.270 |
Why?
|
| Mass Screening | 1 | 2013 | 825 | 0.260 |
Why?
|
| Epithelial Cells | 3 | 2008 | 900 | 0.260 |
Why?
|
| Gastric Bypass | 1 | 2008 | 96 | 0.260 |
Why?
|
| Protein Kinase C | 5 | 2006 | 114 | 0.260 |
Why?
|
| Amiloride | 9 | 1998 | 24 | 0.250 |
Why?
|
| Rabbits | 14 | 1998 | 633 | 0.240 |
Why?
|
| Trans-Activators | 4 | 2005 | 692 | 0.240 |
Why?
|
| Genes, APC | 1 | 2005 | 13 | 0.240 |
Why?
|
| Bacterial Infections | 1 | 2009 | 326 | 0.240 |
Why?
|
| Cell Nucleus | 5 | 2008 | 567 | 0.230 |
Why?
|
| Pectins | 2 | 2003 | 10 | 0.220 |
Why?
|
| Attitude to Health | 1 | 2006 | 251 | 0.220 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2004 | 31 | 0.220 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 2003 | 8 | 0.210 |
Why?
|
| Membrane Potentials | 7 | 2006 | 297 | 0.200 |
Why?
|
| Stem Cells | 1 | 2008 | 713 | 0.200 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 227 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2015 | 303 | 0.200 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 212 | 0.200 |
Why?
|
| Constipation | 2 | 2008 | 130 | 0.200 |
Why?
|
| Cyclic AMP | 5 | 2006 | 229 | 0.190 |
Why?
|
| Propionates | 2 | 1994 | 34 | 0.190 |
Why?
|
| Databases, Factual | 1 | 2007 | 1224 | 0.190 |
Why?
|
| Glycoproteins | 1 | 2004 | 349 | 0.190 |
Why?
|
| Immunoprecipitation | 3 | 2008 | 191 | 0.190 |
Why?
|
| Chlorides | 7 | 2000 | 99 | 0.190 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 225 | 0.190 |
Why?
|
| Male | 32 | 2018 | 65274 | 0.180 |
Why?
|
| Fluid Therapy | 2 | 1999 | 145 | 0.180 |
Why?
|
| Patient Selection | 1 | 2005 | 726 | 0.180 |
Why?
|
| Escherichia coli Proteins | 1 | 2003 | 311 | 0.170 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2014 | 87 | 0.170 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 1912 | 0.170 |
Why?
|
| Bicarbonates | 5 | 1998 | 98 | 0.170 |
Why?
|
| Liver | 1 | 2008 | 1799 | 0.160 |
Why?
|
| Cholera Toxin | 1 | 1999 | 43 | 0.150 |
Why?
|
| Vibrio cholerae | 1 | 1999 | 32 | 0.150 |
Why?
|
| Cholera | 1 | 1999 | 38 | 0.150 |
Why?
|
| Adult | 15 | 2018 | 31700 | 0.150 |
Why?
|
| Epinephrine | 8 | 1998 | 150 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 1413 | 0.150 |
Why?
|
| Colonic Diseases | 2 | 2010 | 37 | 0.150 |
Why?
|
| Drinking | 1 | 1999 | 28 | 0.150 |
Why?
|
| Defecation | 1 | 1999 | 35 | 0.150 |
Why?
|
| Postoperative Complications | 3 | 2014 | 3133 | 0.150 |
Why?
|
| Zinc | 1 | 1999 | 128 | 0.150 |
Why?
|
| Female | 20 | 2018 | 71214 | 0.150 |
Why?
|
| Organ Transplantation | 1 | 2001 | 172 | 0.140 |
Why?
|
| Animals | 26 | 2010 | 34404 | 0.140 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2006 | 48 | 0.140 |
Why?
|
| Citrobacter rodentium | 3 | 2010 | 6 | 0.140 |
Why?
|
| TCF Transcription Factors | 2 | 2008 | 14 | 0.140 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2008 | 59 | 0.130 |
Why?
|
| Immunohistochemistry | 3 | 2008 | 1610 | 0.130 |
Why?
|
| Enterobacteriaceae Infections | 4 | 2010 | 58 | 0.130 |
Why?
|
| Intestinal Secretions | 1 | 2016 | 3 | 0.130 |
Why?
|
| Hemoglobins | 1 | 2018 | 314 | 0.130 |
Why?
|
| Prognosis | 3 | 2018 | 4953 | 0.130 |
Why?
|
| Colitis | 2 | 2009 | 159 | 0.120 |
Why?
|
| Biomarkers, Tumor | 1 | 2004 | 1617 | 0.120 |
Why?
|
| Cyclin D1 | 2 | 2008 | 109 | 0.120 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2018 | 140 | 0.120 |
Why?
|
| Fatty Acids | 1 | 1998 | 377 | 0.110 |
Why?
|
| Middle Aged | 11 | 2018 | 28892 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 1998 | 428 | 0.110 |
Why?
|
| Mesalamine | 1 | 2015 | 6 | 0.110 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 132 | 0.110 |
Why?
|
| Medically Uninsured | 1 | 2015 | 77 | 0.110 |
Why?
|
| Protective Factors | 1 | 2015 | 93 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2015 | 85 | 0.110 |
Why?
|
| Recurrence | 2 | 2018 | 1483 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 63 | 0.110 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 152 | 0.110 |
Why?
|
| Acid-Base Equilibrium | 2 | 1994 | 60 | 0.110 |
Why?
|
| Steatorrhea | 1 | 2014 | 1 | 0.110 |
Why?
|
| Pancreatic Function Tests | 1 | 2014 | 3 | 0.110 |
Why?
|
| Incidence | 3 | 2009 | 3349 | 0.110 |
Why?
|
| Omeprazole | 1 | 1994 | 101 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2008 | 1571 | 0.100 |
Why?
|
| In Vitro Techniques | 6 | 1992 | 824 | 0.100 |
Why?
|
| Texas | 2 | 2015 | 3622 | 0.100 |
Why?
|
| Tertiary Care Centers | 1 | 2015 | 251 | 0.100 |
Why?
|
| Mice | 9 | 2010 | 18482 | 0.100 |
Why?
|
| Information Dissemination | 1 | 2016 | 195 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 570 | 0.100 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1993 | 52 | 0.100 |
Why?
|
| Fatty Acids, Volatile | 3 | 2001 | 45 | 0.100 |
Why?
|
| Peptide Hormones | 1 | 2014 | 71 | 0.100 |
Why?
|
| China | 1 | 2014 | 287 | 0.100 |
Why?
|
| Parenteral Nutrition Solutions | 1 | 2012 | 5 | 0.100 |
Why?
|
| Mentors | 1 | 2014 | 160 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2013 | 192 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2005 | 1018 | 0.100 |
Why?
|
| Insurance Benefits | 1 | 2012 | 4 | 0.090 |
Why?
|
| Biological Products | 1 | 2015 | 144 | 0.090 |
Why?
|
| Social Security | 1 | 2012 | 2 | 0.090 |
Why?
|
| Intestinal Obstruction | 1 | 2013 | 87 | 0.090 |
Why?
|
| Aged | 6 | 2018 | 21259 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 643 | 0.090 |
Why?
|
| Anions | 1 | 1992 | 15 | 0.090 |
Why?
|
| Colon, Sigmoid | 1 | 1992 | 12 | 0.090 |
Why?
|
| Risk Factors | 4 | 2015 | 10961 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2007 | 1626 | 0.090 |
Why?
|
| Cadherins | 2 | 2004 | 178 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 2353 | 0.090 |
Why?
|
| Esophagus | 1 | 1993 | 238 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2015 | 1235 | 0.090 |
Why?
|
| Gastroenterology | 1 | 2014 | 220 | 0.090 |
Why?
|
| Faculty, Medical | 1 | 2014 | 270 | 0.090 |
Why?
|
| Gastrointestinal Transit | 2 | 2007 | 28 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1406 | 0.090 |
Why?
|
| Ion Transport | 3 | 1998 | 48 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2018 | 17662 | 0.090 |
Why?
|
| Potassium | 5 | 1992 | 270 | 0.080 |
Why?
|
| Methylprednisolone | 2 | 1992 | 97 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 2008 | 26 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 505 | 0.080 |
Why?
|
| Enteral Nutrition | 1 | 2012 | 281 | 0.080 |
Why?
|
| Barrett Esophagus | 1 | 1994 | 358 | 0.080 |
Why?
|
| TRPV Cation Channels | 1 | 2010 | 47 | 0.080 |
Why?
|
| Loperamide | 1 | 2009 | 8 | 0.080 |
Why?
|
| Theophylline | 5 | 1992 | 23 | 0.080 |
Why?
|
| Water-Electrolyte Balance | 3 | 2001 | 81 | 0.080 |
Why?
|
| Octreotide | 1 | 2009 | 24 | 0.080 |
Why?
|
| Clonidine | 1 | 2009 | 30 | 0.080 |
Why?
|
| Biological Transport | 4 | 1992 | 333 | 0.080 |
Why?
|
| Sweetening Agents | 1 | 2009 | 37 | 0.080 |
Why?
|
| Calcium Channels | 1 | 2010 | 148 | 0.080 |
Why?
|
| International Cooperation | 1 | 2010 | 161 | 0.070 |
Why?
|
| Physicians | 1 | 2016 | 634 | 0.070 |
Why?
|
| Transcription Factor 4 | 1 | 2008 | 12 | 0.070 |
Why?
|
| Frozen Sections | 1 | 2008 | 28 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 5297 | 0.070 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 37 | 0.070 |
Why?
|
| Celiac Disease | 1 | 2009 | 75 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2018 | 5122 | 0.070 |
Why?
|
| Sodium Channels | 1 | 1989 | 99 | 0.070 |
Why?
|
| Gastrointestinal Motility | 2 | 2016 | 61 | 0.070 |
Why?
|
| Protein Stability | 1 | 2008 | 166 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 3836 | 0.070 |
Why?
|
| Acetylation | 1 | 2008 | 181 | 0.070 |
Why?
|
| Glucose | 2 | 1992 | 848 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2007 | 3093 | 0.070 |
Why?
|
| Cytoskeleton | 2 | 2006 | 167 | 0.070 |
Why?
|
| Electric Conductivity | 4 | 1989 | 80 | 0.070 |
Why?
|
| Metformin | 1 | 2009 | 168 | 0.070 |
Why?
|
| Protein Transport | 1 | 2008 | 362 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 1991 | 1024 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2005 | 420 | 0.070 |
Why?
|
| Sigmoidoscopy | 1 | 2007 | 11 | 0.060 |
Why?
|
| Gastroparesis | 1 | 2008 | 69 | 0.060 |
Why?
|
| Axin Protein | 1 | 2006 | 18 | 0.060 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2006 | 25 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2007 | 81 | 0.060 |
Why?
|
| Threonine | 1 | 2006 | 62 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 198 | 0.060 |
Why?
|
| Proteasome Inhibitors | 1 | 2006 | 57 | 0.060 |
Why?
|
| Bortezomib | 1 | 2006 | 74 | 0.060 |
Why?
|
| Boronic Acids | 1 | 2006 | 49 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 98 | 0.060 |
Why?
|
| Dietary Fiber | 2 | 2003 | 78 | 0.060 |
Why?
|
| Pyrazines | 1 | 2006 | 78 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2006 | 95 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 1170 | 0.060 |
Why?
|
| Specimen Handling | 1 | 2007 | 149 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 741 | 0.060 |
Why?
|
| Cell Membrane Permeability | 1 | 1986 | 67 | 0.060 |
Why?
|
| Epithelium | 3 | 1996 | 343 | 0.060 |
Why?
|
| Serine | 1 | 2006 | 163 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 2122 | 0.060 |
Why?
|
| Colonoscopy | 2 | 2007 | 247 | 0.060 |
Why?
|
| Osmolar Concentration | 2 | 2016 | 148 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 242 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 475 | 0.060 |
Why?
|
| Demography | 1 | 2006 | 243 | 0.060 |
Why?
|
| Barium | 2 | 2003 | 14 | 0.060 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2004 | 12 | 0.060 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2004 | 25 | 0.060 |
Why?
|
| Intestines | 2 | 2016 | 592 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2010 | 2483 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 609 | 0.050 |
Why?
|
| Perception | 1 | 2006 | 229 | 0.050 |
Why?
|
| Jejunum | 2 | 1984 | 124 | 0.050 |
Why?
|
| Citrobacter freundii | 2 | 2001 | 3 | 0.050 |
Why?
|
| Age Factors | 2 | 2014 | 2872 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 363 | 0.050 |
Why?
|
| Video Recording | 2 | 2003 | 208 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 1 | 1984 | 58 | 0.050 |
Why?
|
| Amphotericin B | 3 | 1992 | 90 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2005 | 322 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1395 | 0.050 |
Why?
|
| Adhesins, Bacterial | 1 | 2003 | 71 | 0.050 |
Why?
|
| Hydrogen | 2 | 1994 | 42 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2003 | 45 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2014 | 3696 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1236 | 0.050 |
Why?
|
| Algorithms | 1 | 2009 | 1685 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 1130 | 0.050 |
Why?
|
| Prevalence | 1 | 2009 | 2695 | 0.050 |
Why?
|
| Protein Binding | 1 | 2006 | 1712 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 1253 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6915 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2003 | 195 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2006 | 781 | 0.050 |
Why?
|
| Ouabain | 3 | 1990 | 17 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3916 | 0.040 |
Why?
|
| Adolescent | 2 | 2014 | 20987 | 0.040 |
Why?
|
| Base Sequence | 1 | 2005 | 2783 | 0.040 |
Why?
|
| Radiography | 1 | 2003 | 762 | 0.040 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2001 | 28 | 0.040 |
Why?
|
| Taurodeoxycholic Acid | 2 | 1991 | 3 | 0.040 |
Why?
|
| DNA | 1 | 2006 | 1442 | 0.040 |
Why?
|
| Time Factors | 2 | 2008 | 6280 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2001 | 254 | 0.040 |
Why?
|
| Rehydration Solutions | 1 | 1999 | 8 | 0.040 |
Why?
|
| Kinetics | 3 | 2000 | 1104 | 0.040 |
Why?
|
| Young Adult | 1 | 2014 | 10099 | 0.040 |
Why?
|
| Cyclic GMP | 2 | 1990 | 90 | 0.040 |
Why?
|
| Isotonic Solutions | 1 | 1999 | 37 | 0.040 |
Why?
|
| Absorption | 2 | 1992 | 50 | 0.040 |
Why?
|
| Urination | 1 | 1999 | 27 | 0.040 |
Why?
|
| Phenotype | 1 | 2008 | 4528 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2003 | 1024 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2000 | 464 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2014 | 12993 | 0.030 |
Why?
|
| Water | 1 | 1999 | 190 | 0.030 |
Why?
|
| Ions | 2 | 1990 | 25 | 0.030 |
Why?
|
| Ion Channels | 2 | 1990 | 206 | 0.030 |
Why?
|
| Prostaglandins | 1 | 2016 | 37 | 0.030 |
Why?
|
| Proctitis | 1 | 1996 | 6 | 0.030 |
Why?
|
| Substance P | 1 | 2016 | 32 | 0.030 |
Why?
|
| Chromogranins | 1 | 2016 | 30 | 0.030 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1988 | 20 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 600 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 120 | 0.030 |
Why?
|
| Enema | 1 | 1996 | 47 | 0.030 |
Why?
|
| HT29 Cells | 2 | 2006 | 44 | 0.030 |
Why?
|
| Protein Kinase C beta | 2 | 2006 | 17 | 0.030 |
Why?
|
| Lactoferrin | 1 | 2016 | 76 | 0.030 |
Why?
|
| Microtubules | 1 | 1996 | 128 | 0.030 |
Why?
|
| Ion Channel Gating | 2 | 2006 | 121 | 0.030 |
Why?
|
| Serotonin | 1 | 2016 | 212 | 0.030 |
Why?
|
| Radiation Injuries | 1 | 1996 | 146 | 0.030 |
Why?
|
| Biopsy | 2 | 1992 | 1252 | 0.030 |
Why?
|
| Furosemide | 2 | 2000 | 35 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2006 | 590 | 0.030 |
Why?
|
| Coumaric Acids | 1 | 1994 | 1 | 0.030 |
Why?
|
| Diffusion | 1 | 1994 | 59 | 0.030 |
Why?
|
| Carboxylic Acids | 1 | 1994 | 25 | 0.030 |
Why?
|
| Survival Rate | 1 | 1999 | 2151 | 0.030 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2016 | 217 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 455 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 263 | 0.030 |
Why?
|
| Ethacrynic Acid | 1 | 1992 | 4 | 0.020 |
Why?
|
| Nystatin | 1 | 1992 | 2 | 0.020 |
Why?
|
| Desoxycorticosterone | 1 | 1992 | 12 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2014 | 366 | 0.020 |
Why?
|
| Obesity | 1 | 1984 | 2390 | 0.020 |
Why?
|
| Cell Movement | 1 | 1996 | 886 | 0.020 |
Why?
|
| Technetium | 1 | 1992 | 16 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 1993 | 154 | 0.020 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1992 | 1 | 0.020 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1992 | 1 | 0.020 |
Why?
|
| Conductometry | 1 | 1992 | 2 | 0.020 |
Why?
|
| Carbonates | 1 | 1992 | 7 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1992 | 120 | 0.020 |
Why?
|
| Chlorine | 1 | 1992 | 15 | 0.020 |
Why?
|
| Child | 2 | 2005 | 26307 | 0.020 |
Why?
|
| Acetazolamide | 1 | 1992 | 27 | 0.020 |
Why?
|
| Biological Transport, Active | 2 | 1991 | 73 | 0.020 |
Why?
|
| Duodenal Neoplasms | 1 | 1991 | 28 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 418 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1992 | 241 | 0.020 |
Why?
|
| Second Messenger Systems | 1 | 1990 | 11 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1990 | 43 | 0.020 |
Why?
|
| Bumetanide | 1 | 1990 | 5 | 0.020 |
Why?
|
| Calcium | 3 | 1984 | 1041 | 0.020 |
Why?
|
| Citrobacter | 2 | 2000 | 21 | 0.020 |
Why?
|
| Calcitriol | 1 | 2010 | 62 | 0.020 |
Why?
|
| Cytosol | 2 | 2000 | 140 | 0.020 |
Why?
|
| Deoxycholic Acid | 1 | 1989 | 14 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1994 | 1139 | 0.020 |
Why?
|
| Electrolytes | 1 | 1989 | 58 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1989 | 129 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1990 | 272 | 0.020 |
Why?
|
| Inflammation | 1 | 2016 | 1493 | 0.020 |
Why?
|
| Diverticulum, Colon | 1 | 1988 | 3 | 0.020 |
Why?
|
| Sulfhydryl Reagents | 1 | 1988 | 7 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1990 | 432 | 0.020 |
Why?
|
| Arteriovenous Malformations | 1 | 1988 | 47 | 0.020 |
Why?
|
| Gluconates | 1 | 1987 | 3 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 566 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1988 | 252 | 0.020 |
Why?
|
| Choline | 1 | 1987 | 51 | 0.020 |
Why?
|
| Emergencies | 1 | 1988 | 180 | 0.020 |
Why?
|
| Colforsin | 2 | 2000 | 46 | 0.020 |
Why?
|
| Hospitalization | 1 | 2014 | 1942 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1991 | 579 | 0.010 |
Why?
|
| Calcifediol | 1 | 1984 | 13 | 0.010 |
Why?
|
| Calcimycin | 1 | 1984 | 19 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1991 | 998 | 0.010 |
Why?
|
| Albumins | 1 | 1984 | 92 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1984 | 77 | 0.010 |
Why?
|
| Magnesium | 1 | 1984 | 121 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 1984 | 108 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1999 | 15051 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 1 | 2001 | 4 | 0.010 |
Why?
|
| Microvilli | 1 | 2001 | 65 | 0.010 |
Why?
|
| Butyrates | 1 | 2001 | 41 | 0.010 |
Why?
|
| Rats | 2 | 2001 | 3460 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 1980 | 27 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2000 | 161 | 0.010 |
Why?
|
| Antibodies | 1 | 2000 | 358 | 0.010 |
Why?
|
| Indoles | 1 | 2000 | 205 | 0.010 |
Why?
|
| United States | 1 | 2014 | 11812 | 0.010 |
Why?
|
| Pyrroles | 1 | 2000 | 186 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2000 | 482 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 580 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1996 | 38 | 0.010 |
Why?
|
| Hepatocyte Growth Factor | 1 | 1996 | 33 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1996 | 97 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1996 | 200 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 3616 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 2969 | 0.010 |
Why?
|
| Dogs | 1 | 1996 | 630 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2000 | 1398 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2000 | 2569 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1984 | 6507 | 0.010 |
Why?
|
| Wound Healing | 1 | 1996 | 476 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1996 | 1457 | 0.010 |
Why?
|
| Gallic Acid | 1 | 1991 | 4 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1991 | 75 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 1991 | 111 | 0.010 |
Why?
|
| Cell Line | 1 | 1996 | 2606 | 0.010 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 1990 | 4 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1991 | 646 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2000 | 4683 | 0.000 |
Why?
|
| Calcium Radioisotopes | 1 | 1984 | 1 | 0.000 |
Why?
|
| Calcium Chloride | 1 | 1984 | 23 | 0.000 |
Why?
|
| Polymers | 1 | 1984 | 112 | 0.000 |
Why?
|
| Osteomalacia | 1 | 1980 | 7 | 0.000 |
Why?
|
| Vitamin D | 1 | 1980 | 194 | 0.000 |
Why?
|